TP53 and neoplasm: In principle, complete inactivation of the tumor suppressor TP53 (p53) by mutations and p53 loss-of-heterozygosity is a hallmark event during tumorigenesis and affects tumor biology by increasing cell proliferation, invasion and therapy resistances [62–65].